Concepedia

Marta Braschi‐Amirfarzan

MB

Statistics

Publications

10

Citations

286

H-Index

10

Active since

2015

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Harvard University

Icahn School of Medicine at Mount Sinai

University of Miami

Marta Braschi‐Amirfarzan is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and pathology.

Top concepts

Publications per year

2015–2022

10

Publications

10

Value of hepatocellular phase imaging after intravenous gadoxetate disodium for assessing hepatic metastases from gastroenteropancreatic neuroendocrine tumors: comparison with other MRI pulse sequences and with extracellular agent

Sree Harsha Tirumani, Jyothi P. Jagannathan, Marta Braschi‐Amirfarzan et al. · Abdominal Radiology · 2018 · 49 citations

, , +16

Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic Colitis

Shilpa Grover, Alex Ruan, Padmavathi Srivoleti et al. · JCO Oncology Practice · 2020 · 46 citations

A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials

Kathleen Ruchalski, Marta Braschi‐Amirfarzan, Michael Douek et al. · Radiology Imaging Cancer · 2021 · 35 citations · Full text

Extracutaneous melanomas: a primer for the radiologist

Abhishek Keraliya, Katherine M. Krajewski, Marta Braschi‐Amirfarzan et al. · Insights into Imaging · 2015 · 33 citations · Full text

Imaging features of toxicities associated with immune checkpoint inhibitors

Babina Gosangi, Lacey McIntosh, Abhishek Keraliya et al. · European Journal of Radiology Open · 2022 · 28 citations · Full text

, , +18

Rows per page

1–5 of 10